Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-10-4
pubmed:abstractText
Procollagen type 1 is mainly synthesized by osteoblasts and, after cleavage of the N- and C-terminal extension peptides, is utilized for collagen fibril deposition in the osteoid tissue. Serum levels of C-terminal extension peptide (Pcoll-1-C) of the procollagen molecule has been considered a useful marker for the evaluation of the rate of osteoblastic procollagen synthesis. To appraise whether in vivo parathyroid hormone (PTH) plays a suppressive role in the synthesis of procollagen type 1, a study has been carried out in 16 patients, 10 with severe secondary hyperparathyroidism of chronic renal failure and 6 with primary hyperparathyroidism. Following parathyroidectomy (PTX), in chronic renal failure patients a 94% fall in serum intact iPTH and a decline of serum calcium to hypocalcemic levels requiring calcitriol administration were observed. Serum Pcoll-1-C increased markedly with a peak after 7 days and a subsequent decline. Similar changes were observed for alkaline phosphatase and osteocalcin. In primary hyperparathyroidism, PTX was followed by an 88% drop in iPTH and mild hypocalcemia not requiring calcitriol administration. Also in this group serum Pcoll-1-C increased significantly with the same time course, unaccompanied by changes in alkaline phosphatase and osteocalcin. In 4 unsuccessfully neck-operated control patients no change in serum Pcoll-1-C levels was recorded during a period of 2 weeks postoperatively. In conclusion, acute withholding of parathyroid hypersecretion is accompanied by an abrupt and transitory increase of serum Pcoll-1-C, not dependent on calcitriol administration. Hypocalcemia following PTX may in part be due to uncoupling of bone formation and resorption.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-8095
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
106-12
pubmed:dateRevised
2007-2-14
pubmed:meshHeading
pubmed-meshheading:8080002-Adult, pubmed-meshheading:8080002-Aged, pubmed-meshheading:8080002-Alkaline Phosphatase, pubmed-meshheading:8080002-Biological Markers, pubmed-meshheading:8080002-Calcitriol, pubmed-meshheading:8080002-Chronic Disease, pubmed-meshheading:8080002-Female, pubmed-meshheading:8080002-Humans, pubmed-meshheading:8080002-Hyperparathyroidism, pubmed-meshheading:8080002-Hyperparathyroidism, Secondary, pubmed-meshheading:8080002-Kidney Failure, Chronic, pubmed-meshheading:8080002-Male, pubmed-meshheading:8080002-Middle Aged, pubmed-meshheading:8080002-Osteocalcin, pubmed-meshheading:8080002-Parathyroid Hormone, pubmed-meshheading:8080002-Parathyroidectomy, pubmed-meshheading:8080002-Peptide Fragments, pubmed-meshheading:8080002-Postoperative Care, pubmed-meshheading:8080002-Preoperative Care, pubmed-meshheading:8080002-Procollagen, pubmed-meshheading:8080002-Severity of Illness Index
pubmed:year
1994
pubmed:articleTitle
Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients.
pubmed:affiliation
Chair of Nephrology, 3rd Surgical Clinic, La Sapienza University, Rome, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't